Case report shows complete remission of atypical non-leg cutaneous diffuse large B-cell lymphoma following R-CHOP chemotherapy, highlighting the efficacy of systemic therapy in rare presentations.
Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL-LT), is an aggressive subtype of primary cutaneous B-cell lymphoma that predominantly affects the lower extremities of elderly individuals. We report a rare case of a 79-year-old woman presenting with rapidly enlarging, erythematous-to-violaceous tumors and plaques on the face, chest, left upper arm, and upper back, an uncommon non-leg manifestation of PCDLBCL-LT, confirmed by histopathology and immunohistochemistry. The patient was successfully treated with six cycles of the rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) therapy, achieving complete remission with no relapse during 1.5 years of follow-up. This case emphasizes that PCDLBCL-LT can present in locations outside the legs, highlighting the need for early recognition and systemic therapy in atypical locations.
No takes yet. Share an insight, caveat, or question.
Panagiotidis et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: